Smart for Life (SMFL) Competitors $0.0086 +0.00 (+28.36%) As of 02:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMFL vs. SCPS, VAXX, CALA, CMRA, GNCAQ, GNCA, ARDS, STAB, AMPE, and CLVRShould you be buying Smart for Life stock or one of its competitors? The main competitors of Smart for Life include Scopus BioPharma (SCPS), Vaxxinity (VAXX), Calithera Biosciences (CALA), Comera Life Sciences (CMRA), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), Ampio Pharmaceuticals (AMPE), and Clever Leaves (CLVR). These companies are all part of the "pharmaceutical products" industry. Smart for Life vs. Scopus BioPharma Vaxxinity Calithera Biosciences Comera Life Sciences Genocea Biosciences Genocea Biosciences Aridis Pharmaceuticals Statera Biopharma Ampio Pharmaceuticals Clever Leaves Scopus BioPharma (NASDAQ:SCPS) and Smart for Life (NASDAQ:SMFL) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, community ranking, risk and valuation. Which has more volatility & risk, SCPS or SMFL? Scopus BioPharma has a beta of -0.23, suggesting that its stock price is 123% less volatile than the S&P 500. Comparatively, Smart for Life has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500. Does the MarketBeat Community believe in SCPS or SMFL? Scopus BioPharma received 1 more outperform votes than Smart for Life when rated by MarketBeat users. CompanyUnderperformOutperformScopus BioPharmaOutperform Votes2100.00% Underperform VotesNo VotesSmart for LifeOutperform Votes1100.00% Underperform VotesNo Votes Which has higher valuation & earnings, SCPS or SMFL? Scopus BioPharma has higher earnings, but lower revenue than Smart for Life. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioScopus BioPharmaN/AN/A-$11.61MN/AN/ASmart for Life$11.11M0.00-$22.68MN/AN/A Is SCPS or SMFL more profitable? Company Net Margins Return on Equity Return on Assets Scopus BioPharmaN/A N/A N/A Smart for Life N/A N/A N/A Does the media prefer SCPS or SMFL? In the previous week, Scopus BioPharma's average media sentiment score of 0.00 equaled Smart for Life'saverage media sentiment score. Company Overall Sentiment Scopus BioPharma Neutral Smart for Life Neutral Do insiders and institutionals believe in SCPS or SMFL? 28.4% of Smart for Life shares are owned by institutional investors. 5.1% of Scopus BioPharma shares are owned by insiders. Comparatively, 31.7% of Smart for Life shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummarySmart for Life beats Scopus BioPharma on 4 of the 6 factors compared between the two stocks. Get Smart for Life News Delivered to You Automatically Sign up to receive the latest news and ratings for SMFL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMFL vs. The Competition Export to ExcelMetricSmart for LifeMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$54,000.00$1.24B$5.56B$8.64BDividend YieldN/AN/A5.27%4.19%P/E RatioN/A12.8627.3020.18Price / Sales0.0010.59415.29164.91Price / CashN/A10.4038.2534.64Price / Book0.001.537.174.73Net Income-$22.68M-$56.07M$3.23B$248.08M7 Day PerformanceN/A4.08%6.81%4.47%1 Month PerformanceN/A4.78%15.59%10.83%1 Year PerformanceN/A-30.27%32.77%15.09% Smart for Life Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMFLSmart for LifeN/A$0.01+28.4%N/A-99.8%$61,000.00$11.11M0.00110Positive NewsGap UpSCPSScopus BioPharmaN/A$0.00flatN/AN/A$13,000.00N/A0.009VAXXVaxxinityN/A$0.00-99.0%N/A-99.9%$13,000.00N/A0.0090Gap UpCALACalithera Biosciences0.6007 of 5 stars$0.00-47.4%N/A-90.0%$10,000.00N/A0.0060Gap UpCMRAComera Life SciencesN/A$0.00flatN/A-99.3%$6,000.00$1.00M0.002GNCAQGenocea BiosciencesN/AN/AN/AN/A$6,000.00N/A0.0070GNCAGenocea BiosciencesN/AN/AN/AN/A$6,000.00$1.91M0.0070ARDSAridis PharmaceuticalsN/A$0.00-66.7%N/A-99.9%$5,000.00$3.09M0.0030Gap DownSTABStatera BiopharmaN/A$0.00flatN/A-83.3%$5,000.00N/A0.0020AMPEAmpio Pharmaceuticals0.218 of 5 stars$0.00flatN/A+0.3%$3,000.00N/A0.0020CLVRClever LeavesN/A$0.00flatN/A-100.0%$1,000.00$17.42M0.00560 Related Companies and Tools Related Companies Scopus BioPharma Competitors Vaxxinity Competitors Calithera Biosciences Competitors Comera Life Sciences Competitors Genocea Biosciences Competitors Genocea Biosciences Competitors Aridis Pharmaceuticals Competitors Statera Biopharma Competitors Ampio Pharmaceuticals Competitors Clever Leaves Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMFL) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGet Ready for Elon Musk’s BIGGEST Comeback YetTesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smart for Life, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Smart for Life With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
